- Home
- TGNA vs OGN Comparison
TGNA vs OGN Comparison
Compare TGNA & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TGNA
- OGN
- Stock Information
- Founded
- TGNA 1906
- OGN 1923
- Country
- TGNA United States
- OGN United States
- Employees
- TGNA N/A
- OGN N/A
- Industry
- TGNA Broadcasting
- OGN Biotechnology: Pharmaceutical Preparations
- Sector
- TGNA Industrials
- OGN Health Care
- Exchange
- TGNA Nasdaq
- OGN Nasdaq
- Market Cap
- TGNA 3.2B
- OGN 2.7B
- IPO Year
- TGNA N/A
- OGN N/A
- Fundamental
- Price
- TGNA $19.96
- OGN $6.79
- Analyst Decision
- TGNA Buy
- OGN Buy
- Analyst Count
- TGNA 4
- OGN 3
- Target Price
- TGNA $20.00
- OGN $17.33
- AVG Volume (30 Days)
- TGNA 1.2M
- OGN 7.5M
- Earning Date
- TGNA 11-07-2025
- OGN 11-10-2025
- Dividend Yield
- TGNA 2.51%
- OGN 1.18%
- EPS Growth
- TGNA 15.85
- OGN N/A
- EPS
- TGNA 2.77
- OGN 2.69
- Revenue
- TGNA $3,032,450,000.00
- OGN $6,281,000,000.00
- Revenue This Year
- TGNA N/A
- OGN N/A
- Revenue Next Year
- TGNA $5.99
- OGN $0.65
- P/E Ratio
- TGNA $7.20
- OGN $2.52
- Revenue Growth
- TGNA 5.89
- OGN N/A
- 52 Week Low
- TGNA $14.87
- OGN $6.18
- 52 Week High
- TGNA $21.35
- OGN $17.23
- Technical
- Relative Strength Index (RSI)
- TGNA 49.72
- OGN 29.47
- Support Level
- TGNA $19.44
- OGN $6.33
- Resistance Level
- TGNA $19.92
- OGN $6.93
- Average True Range (ATR)
- TGNA 0.22
- OGN 0.39
- MACD
- TGNA 0.02
- OGN -0.09
- Stochastic Oscillator
- TGNA 71.53
- OGN 18.94
About TGNA TEGNA Inc
Tegna Inc is a media company with a portfolio of broadcast stations and digital sites. The firm has television stations and radio stations in approximately U.S. markets. The company owns multicast networks of True Crime Network, Twist, and Quest. Each television station also has a robust digital presence across online, mobile, connected television, and social platforms, reaching consumers on all devices and platforms used to consume news content. It generates key revenue from advertising and marketing services, subscriptions, political advertising, and other services.
About OGN Organon & Co.
Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.